This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer | MicrobiomeTrials
← Back to trials NCT03424005
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2018-03-30Est. Completion: 2030-09-30
Enrollment target: 1,132 participantsLocations City of Hope - Duarte, Duarte, California, United States City of Hope, Duarte, California, United States City of Hope - Orange County Lennar Foundation Cancer Center, Irvine, California, United States University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla, California, United States University of California San Diego Medical Center, La Jolla, California, United States UCLA Health 200 Medical Plaza, Los Angeles, California, United States Stanford Cancer Institute, Stanford, California, United States Rocky Mountain Cancer Center - Longmont, Longmont, Colorado, United States H. Lee Moffitt Cancer Center and Research Inst., Tampa, Florida, United States City of Hope® Cancer Center Chicago, Zion, Illinois, United States Metro-Minnesota Community Oncology Research Consortium, Saint Paul, Minnesota, United States Renown Regional Medical Center, Reno, Nevada, United States Hackensack Univ Medical Center, Hackensack, New Jersey, United States Regional Cancer Care Associates, LLC, Howell Township, New Jersey, United States Other microbiome trials you might be interested in Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Estrogen Receptor-Positive Breast Carcinoma HER2-Negative Breast Carcinoma
This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone thera…
Jonesboro, United States Est. completion Jul 31, 2029
Prostate Cancer Leukemia Breast Cancer
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
NYU Langone Medical Center, New York, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Tennessee Oncology - Chattanooga Oncology & Hematology Associates, Chattanooga, Tennessee, United States
The West Clinic, Germantown, Tennessee, United States
Tennessee Oncology PLLC, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Texas Oncology-Plano East, Plano, Texas, United States
Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Victoria, Australia
Fiona Stanley Hospital - Medical Oncology, Murdoch, Western Australia, Australia
Centre Léon Bérard, Lyon, France
Institut régional du Cancer Montpellier, Montpellier, France
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
Gustave Roussy, Villejuif, France
Universitätsklinikum Erlangen, Erlangen, Germany
Universitätsklinikum Essen, Essen, Germany
Rambam Medical Center, Haifa, Israel
Shaare Zedek Medical Center, Jerusalem, Israel
Hadassah University Medical Center, Jerusalem, Israel
Rabin MC, Petah Tikva, Israel
Sheba Medical Center, Ramat Gan, Israel
Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Assuta Medical Centers, Tel Aviv, Israel
National Cancer Center Clinical Trials Center / Center for Breast Cancer, Goyang-si, South Korea
Seoul National University Hospital, Seoul, South Korea
Severance Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Hospital Universitario Virgen Macarena, Seville, Sevilla, Spain
Hospital del Mar, Barcelona, Spain
Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, Spain
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Barts Health NHS Trust - St Bartholomew's Hospital, London, United Kingdom Melanoma
Colorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United States Completed Dec 23, 2027